Reviva Pharmaceuticals Holdings Financial Overview
Reviva Pharmaceuticals Holdings's market cap is currently $70.89M. The company's EPS TTM is $-0.06; its P/E ratio is -1.27; Reviva Pharmaceuticals Holdings is scheduled to report earnings on November 13, 2025, and the estimated EPS forecast is $-0.07. See an overview of income statement, balance sheet, and cash flow financials.
